XNCR Nov 2024 25.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous Close | 1.9000 |
| Open | 1.9000 |
| Bid | 0.5000 |
| Ask | 5.0000 |
| Strike | 25.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 1.9000 - 1.9000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
Simply Wall St.Xencor First Quarter 2024 Earnings: Misses Expectations
Xencor ( NASDAQ:XNCR ) First Quarter 2024 Results Key Financial Results Revenue: US$12.8m (down 33% from 1Q 2023). Net...
- GuruFocus.com
Xencor Inc (XNCR) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
Comprehensive Analysis of Financial Performance and Strategic Initiatives
Business WireXencor Reports First Quarter 2024 Financial Results
PASADENA, Calif., May 09, 2024--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a review of recent clinical and business highlights.
© 2024 Yahoo. All rights reserved.